Skip to content
  • support@editverse.com
  • Home
  • Publication Support Services
    • Publication Support Services (All)
    • Plagiarism Correction Services
    • Response to reviewers (Response letter only)
    • H-Index Boosting Services
    • Word-count Reduction Services
    • Reference Selection
    • Statistical Review
    • Brief Literature Review
    • Scientific Journal Selection Services
    • Brief Literature Review
    • Pre-submission Review Service
    • Referee Recommendations
    • Reference Selection
    • Statistical Review & Analysis Services
    • Response to reviewers (Response letter only)
  • Manuscript Writing Services
    • Manuscript Writing Services ( All)
    • PhD & Dissertation Support Service
    • Patent Writing Services | Professional IP Consultancy & Patent Application Drafting
    • Just Data Service
    • Material and Methods Writing
    • Result and Discussion Writing
    • Abstract Writing Services
    • Introduction writing
    • Case-Report Novelty Statement
    • Cover Letter Writing Services
    • Plagiarism Correction Services
    • Result and Discussion Writing
    • Poster Presentation (Conference/Seminar/Symposium)
    • Re-Writing Package
    • Plagiarism Check and Correction
    • Video Abstract/ Summary
  • Editing & Translation
    • Manuscript Editing Services(All)
    • Substantive Editing
    • Copyediting
    • Proofreading
    • Word-count Reduction Services
    • Translation
      • Japanese to English
      • Korean to English
      • Mandarin to English
      • Turkish to English
      • Portuguese to English
      • Spanish to English
      • German to English
  • R&D Consultancy
    • Clinical Trial Design
    • Literature Review
    • Experiment Design
    • Meta-analysis
    • Data Interpretation
    • Experiment to Publication Consultancy
    • Research Grant Writing Support
  • 日本の研究者のための学術論文執筆支援サービス
  • 台灣學術論文發表服務 | Editverse 專業支援
  • 中国 | 国际期刊发表专业服务 | 香港及内地顶尖高校合作伙伴
  • منصة إديت ڤيرس السعودية | دعم شامل للباحثين وطلاب الدراسات العليا
  • About Us

Drug Development Pipeline

immune tolerance drug development pipeline

The $50 Billion Drug Pipeline That Nobel Prize Medicine Just Validated

Discover how the 2024 Nobel Prize in Medicine validates the $50B+ immune tolerance drug development pipeline, driving innovation in clinical trials and FDA approvals.

Category : SciNews Autoimmune Diseases, Biopharmaceuticals, Drug Development Pipeline, Immune Tolerance, Immunological Research, Immunotherapy, Nobel Prize Medicine, Therapeutic Innovations Read More

Product categories

  • Consultancy Services (3)
  • Editing Services (5)
  • Just Data Services (1)
  • Publication Support Services (36)
  • Translation Services (1)
  • Writing Services (28)

SAFE | SECURE | Ethical Website

Editverse is a completely secure website.  All your information is protected and will never be shared with a third party.  We are protected by SSL, Mcafee Secure and Google’s reCAPTCHA.  We are committed to following COPE guidelines in all of our services.

SSL Secure

McAfee Secure Website

Every McAfee SECURE certified site is tested and certified to be free of malware, viruses, phishing attacks, and other things that can harm you and your computer.
McAfee SECURE certified site

Google reCAPTCHA

Career at Editverse

We are hiring. Please send your CV.

Full Time: ca*****@*******se.com

Freelancer: fr*********@*******se.com

What we need!

Please submit your CV if you have any of follwing qualifications and a passion for research.

PhD|MS|MD|MCH|DNB|MSc

For Technical Editing & writing:

Publication in 5+ impact factor Journal and reviewing experience in SCI/SCIE  indexed journals is essential.

Search

Your Orders

If you come across any outdated/incorrect information in this website, kindly email us at co*****@*******se.com to request updates.

Contact Us (US Office)

  • Editverse (Global Operations) |539 W. Commerce St Dallas TX 75208 USA
  • support@editverse.com

联系我们

  • 中国 商业 | China Operations| 要求报价 | hello.china@editverse.com 你可以用中文发邮件给我们

お問い合わせ

  • 日本 事業 | Japan Operations | お見積り依頼 | hello.japan@editverse.com 日本語でメールできます。

Asia Operations

  • Registered Office: Neucite Research Private Limited, Old Diwani ETAWAH Etawa UP 206001 (CIN) U73100UP2019OPC112451

Security | Privacy

Refund Policy 

Privacy Policy

Non-Disclosure Agreement

Publication Ethics

 

Powered by

Editverse is a proud innovation venture of Neucite Research – An R&D Consultancy and Innovation Management Company.

© 2025 Editverse | Designed by: Theme Freesia | Powered by: WordPress
We use cookies on our website to give you the most relevant experience. If you continue to use this site we will assume that you are happy with it.
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT